Gland Pharma's wholly owned subsidiary -- Gland Pharma International PTE, Singapore has entered into a share purchase agreement with FPCI Sino French Midcap Fund to acquire 100% stake in Europe-based Cenexi Group pursuant to the terms of the put option agreement inked in November last year.
Earlier, the company through its wholly owned subsidiary -- Gland Pharma International PTE, Singapore had entered into a Put Option agreement to acquire 100% of Cenexi Group for an equity value not exceeding Euro 120 million (Enterprise Value of Euro 230 million).
Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.
